跳至主要内容
临床试验/JPRN-UMIN000037180
JPRN-UMIN000037180已完成未知

Comparison between ABCD and IMS scores in prediction of long-term T2DM remission after metabolic surgery in East Asian obese patients - Comparison between scoring systems in prediction of T2DM remission after metabolic surgery in East Asian obese patients

Oita University0 个研究点目标入组 24 人开始时间: 2019年7月1日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
入组人数
24

研究概览

简要总结

he two scoring systems were significantly well correlated. The IMS scoring system showed significant differences in T2DM remission rates between the procedures in the moderate stage, but the ABCD score showed no significant differences in each category. The discrimination power of the IMS score was comparable to that of the ABCD score at both 3 and 5 years. The revised IMS scoring system showed that SG-DJB had significantly higher T2DM remission rates in the moderate stage at 5 years than RYGB or SG.

研究设计

研究类型
Observational

入排标准

年龄范围
18years-old 至 65years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • Patients who are not diagnosed as T2DM before operation Patients who have no data of preoperative C-peptide Patients who experienced severe complications such as leakage just after the first operation Patients who received revision surgery within 3 years after the first operation Patients who received pregnancy within 3 years after the first operation Patients who have lack of 3 years data (between 3-4 years) Patients who received other operations than SG, RYGB, resectional RYGB, mini-gastric bypass, and SG-DJB Patients who received open metabolic surgery (not laparoscopic) When patients experienced revision surgery or pregnancy between 4-5 years, 5 years data are only excluded.

研究者

相似试验